The rate of Alzheimer's disease is predicted to triple by the year 2056. The question in personalised medicine is, can genetic screening and targeting modifiable risk factors downgrade the disease onset in identified at-risk individuals? In this week’s episode, nutritional genomics consultant Dr Sasja Beetstra-Hill guides us through the emerging connection the ApoE4 gene is showing as a predictive screening option for Alzheimer's disease risk. Could this assessment lead to earlier intervention and help clinicians and patients get out in front of Alzheimer's disease before it's progressed beyond the reach of therapy? Find today's transcript and show notes here: https://www.fxmedicine.com.au/content/apoe-alzheimers-connection-dr-sasja-beetstra-hill *****DISCLAIMER: The information provided on FX Medicine is for educational and informational purposes only. The information provided is not, nor is it intended to be, a substitute for professional advice or care. Please seek the advice of a qualified health care professional in the event something you learn here raises questions or concerns regarding your health.*****